Antineoplastic agents
Sub categories/Drugs:
- L01A: Alkylating agents
- L01B: Antimetabolites
- L01C: Plant alkaloids and other natural products
- L01D: Cytotoxic antibiotics and related substances
- L01E: Protein kinase inhibitors
- L01FD06: margetuximab
- L01FX19: sabatolimab
- L01FX20: tremelimumab
- L01FX21: naxitamab
- L01FX22: loncastuximab tesirine
- L01FX23: tisotumab vedotin
- L01X: Other antineoplastic agents
Description:
Clinical Syndromes:
Morphological Classes:
References:
NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Antineoplastic agents/adverse effects"[Mesh] OR "Antineoplastic agents/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])
loading references for 'Antineoplastic agents' from pubmed ...
Case Reports: